Introduction {#s1a}
============

mRNA localisation is a common and conserved means of targeting proteins to their site of function, and is important in a diverse range of cellular and developmental functions (reviewed in [@b59]) with clear links to human diseases (Jeibmann et al., 2009).
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Throughout their journey, mRNA transcripts never exist alone; they bind to a number of proteins to form mRNA--protein complexes, the ribonucleoprotein (RNP) complexes, ([Box 1](#box1){ref-type="boxed-text"}) (reviewed in [@b45]). Furthermore, as RNP complexes travel through the cell, there is evidence for dynamic remodeling of these complexes by different trans-acting protein factors that interact with regulatory cis-acting mRNA sequences ([@b68]). These interactions dictate the fate of mRNAs, so an understanding of these interactions is crucial for explaining the precise spatio-temporal control of localisation and translation. These biological processes have proven challenging to study because of the diversity of proteins and mRNA sequences involved. However, there has recently been significant progress owing to innovative experimental approaches ([Box 2](#box2){ref-type="boxed-text"}).

In this Cell Science at a Glance article and accompanying poster, we focus on localised coding mRNAs in polarised or migrating cells. Using a mechanism of 'active transport and anchoring' as a basis for comparison, we follow the fate of mRNA from nuclear export, particle formation (see [Box 1](#box1){ref-type="boxed-text"}), transport, anchoring, translation, to degradation (see poster), highlighting some of the recent exciting findings.

Nuclear export {#s1b}
==============

mRNAs start their journey in the nucleus where they are transcribed from DNA ([@b83]). Nascent transcripts are spliced, typically co-transcriptionally, to generate the coding mRNA in a process that removes introns, followed by the deposition of the exon--junction complex (EJC) and other components necessary for export and localisation ([@b5]; [@b66]; [@b81]). At this point, the emerging mRNAs associate, for the first time, with protein co-factors ([Box 1](#box1){ref-type="boxed-text"}) to form RNP complexes ([@b37]; [@b66]).

A growing theme that emerges from the recent literature is that, even at this early stage, the association of localising mRNAs with proteins in the nucleus can dictate their future fate. First, recent work on the EJC suggests that the formation of RNP multimers through interaction with other EJC complexes and with serine- and arginine-rich (SR) proteins plays a role in packaging mRNAs, and in preparing them for nuclear export ([@b85]). More generally, a host of protein associations is initiated co-transcriptionally in the nucleus and appears to change continually throughout the different stages of mRNA localisation ([@b57]; [@b77]; [@b94]; Trcek et al., 2010). The formation of RNP complexes is directed by specific regions (cis-acting domains), which typically comprise double-stranded secondary structures including hairpins, stem loops and bulges ([@b2]; Hamilton et al., 2007; [@b71]; [@b103]). Second, alternative splicing can redefine or shuffle these cis-acting sequences to generate RNP complexes with varying trans-acting protein composition that dictates differential fates of mRNAs ([@b38]; Trcek et al., 2010). Third, direct interactions of RNP complexes with the nuclear pore complex (NPC) can be essential for the formation of an export- and localisation-competent RNP complex. For example in *Saccharomyces cerevisiae*, mutants for the nucleoporin protein Nup60p, fail to export *ASH1* mRNA from the nucleus and transcripts that are exported do not localise correctly ([@b75]).

Once mRNAs are spliced, RNP complexes become export competent through the addition of further co-factors and diffuse through the interchromatin spaces in the nucleoplasm to the NPC ([@b62]). At the NPC, a conserved and highly complicated structure, they are exported through interactions with co-factors such as nuclear RNA export factor 1 and NTF2-related export protein 1 (NXF1 and NXT1, respectively) and the transcription export complex (TREX), which are essential for nuclear export ([@b66]; [@b77]; [@b97]). In *Drosophila* embryos and rat myoblasts, the export path has been shown to be random ([@b74]; [@b105]). However, the exact routes taken by RNP complexes remains an area of debate and may indeed be polarised with respect to the cell. Recent breakthroughs achieved by using 'super registration' fluorescence microscopy approaches, which allow a direct visualisation of mRNA export in transgenic mouse cell lines ([@b32]), show that not all nuclear pores are equally active at the same time. Furthermore, mRNAs were shown to move bidirectionally through the pores, with docking at and release from the nuclear pore being the rate-limiting steps, rather than translocation through the channel. There is also evidence that translocation of a large RNP complex through a channel of limited diameter is facilitated by RNA helicases, which are essential for nuclear export and mRNA quality control (reviewed in [@b97]), and can specifically interact with nucleoporins and promote mRNA remodeling ([@b61]).

Interestingly, export through the NPC is not the only path to the cytoplasm. Recently, an alternative mechanism has been discovered in the *Drosophila* neuromuscular junction where large RNP complexes exit the nucleus through vesicular budding ([@b44]; [@b88]), a process thought to be utilized by some DNA viruses. Regardless of the underlying mechanism, once the mRNA has arrived at the cytoplasmic face of the nucleus, it is ready for the next phase of its journey.

Transport and anchoring {#s1c}
=======================

Early studies of mRNA transport in the cytoplasm focused on the overall localisation of transcripts through the visualisation of endogenous mRNA by *in situ* hybridisation ([@b42]; [@b49]; [@b100]). The subsequent development of the MS2 bacteriophage RNA stem loop bound by MS2 coat protein fusion to a fluorescent protein (MS2-MCP system) and recent imaging advances (see [Box 2](#box2){ref-type="boxed-text"}) combined with the use of mutants that affect transacting protein factors, motors and the cytoskeleton, and also drug treatments, showed that different mRNAs localise by means of different mechanisms ([@b6]; Forrest et al., 2003; [@b41]; [@b50]; [@b59]; [@b92]). For example, in late *Drosophila* oogenesis, *bicoid* (*bcd*) is localised by active transport and *nanos* (*nos*) is localised by means of diffusion and trapping (Forrest et al., 2003; [@b99]). Biochemical experiments have supported and expanded our understanding of the trans-acting factors that are required for the regulation of these processes ([@b58]; [@b64]; [@b87]). The classic view of RNP complexes is that they are composed of higher order mRNA complexes. This certainly appears to be the case for *oskar* (*osk*) mRNA, where multiple mRNA particles associate with each other to form large transport particles or granules ([@b19]; [@b45]). However, recent research following individual mRNAs indicates that oligomerisation is not obligatory for transport ([@b2]). In this section, we focus primarily on the current understanding of mRNA localisation along microtubules by means of active motor-dependent transport in polarised cells. This is exemplified by the classic axis-determining mRNAs in *Drosophila* that move on microtubule tracks, with kinesin transporting *osk* mRNA in the plus-end direction and dynein driving *gurken* (*grk*) mRNA transport to the microtubule minus end ([@b55]; [@b110]).

An essential requirement for localisation is the linkage of the correct motor to the cargo and the connection of this complex to the cytoskeleton. Bicaudal-D (BicD) and Egalitarian (Egl) are two linkers with key roles in axis determination in *Drosophila* oocytes and embryos ([@b56]; [@b11]; [@b67]). Egl directly binds to different cis-acting elements that mediate mRNA localisation and BicD regulates the linkage of mRNA cargo to dynein. A recent study provides insight into the molecular mechanism of motor protein recruitment by solving the crystal structure of the cargo-binding domain of BicD ([@b53]), which shows that cargo binds to the homotypic domain of BicD and releases the auto inhibition of its heterotypic coiled-coil domain, thus allowing this domain to bind to dynein.

Work *in vitro* has suggested that the number of motors that are recruited to an RNP complex can be controlled by cis-acting localisation elements in the mRNA ([@b2]). Similarly, recruitment of multiple copies of the class V myosin Myo4 by She2 has been shown to enhance transport of *ASH1* mRNA along actin in *S. cerevisiae* ([@b21]). Additional levels of regulating transport efficiency also exist, for instance mediated by proteins such as Pat1, which interacts with cargo adaptors to regulate the motility of kinesin heavy chain on microtubules and is necessary for *osk* mRNA localisation ([@b54]). The microtubule-associated protein (MAP) ensconsin interacts with microtubules and kinesin-1 to increase efficiency of motor recruitment ([@b91]). This is different to typical MAPs, which affect cytoskeletal stability and organisation.

The classic model of mRNA localisation poses that it is underpinned by a highly polarised cytoskeletal network ([@b22]). This model predicts that mRNAs exhibit a concerted directional motion. However, research on the dynamics of RNP complexes often shows a non-uniform rather than continuous, processive movement ([@b86]). One explanation for this is that the dynein motor is capable of reversing direction ([@b31]). Another explanation comes from recent *in vivo* and *in vitro* analysis that has shown that individual mRNA cargos can undergo bidirectional movement owing to transport by multiple motors. In the case of *Vg1* mRNA in frogs, there are different phases of transport during localisation. An initial highly unidirectional dynein-dependent phase is followed by multiple rounds of bidirectional transport for which kinesin-1, kinesin-2 and dynein are required, before transcripts are anchored at the vegetal cortex ([@b28]).

In *Drosophila* oocytes, live imaging of *osk* mRNA and visualisation of microtubules using green fluorescent protein (GFP) tagged to end-binding protein 1 (EB1) revealed an apparently random organisation with subtle bias towards the posterior, rather than the expected highly polarised cytoskeletal network ([@b70]; [@b110]). Additional control of transport can be mediated through the regulation of the properties of the tracks themselves ([@b29]), such as regulating the extension and catastrophic collapse of microtubules.

Once the mRNA has reached its destination, anchoring is a common mechanism for maintaining mRNA localisation. For example *grk* mRNA is anchored by dynein at the *Drosophila* oocyte dorsal anterior corner, whereas *nos* mRNA that is diffusing in the ooplasm is trapped by actin at the posterior pole ([@b25]; Forrest et al., 2003). In *Xenopus*, *Vg1* mRNA is maintained at the vegetal pole of the oocyte by the actin cytoskeleton ([@b108]).

Actin has also been implicated in the organisation and function of the microtubule cytoskeleton and has been demonstrated to be of particular importance for the localisation of *bicoid* mRNA ([@b101]) and in organising a polarised microtubule cytoskeleton in the *Drosophila* oocyte ([@b23]). Actin can also function as a track on which cargoes can be transported. Here, actin not only acts in the short-range localisation of mRNAs, as is the case for *ASH1* mRNA in yeast ([@b6]), but also in long-range vesicle transport in mouse oocytes (Schuh et al., 2011; reviewed in [@b89]). Together, these examples demonstrate that there is no clear universal mechanism for mRNA transport. The future challenge is to understand to what extent the differential localisation of mRNA species is achieved through distinct transport mechanisms that operate in parallel.

Translation {#s1d}
===========

For effective localised protein expression, mRNAs are kept translationally silent during transport and are activated for translation when they are anchored at their destination. Cis-acting mRNA sequences are almost certainly responsible for both the translational repression of mRNAs and their activation by directing their interaction with trans-acting proteins. Several strategies have been proposed, including the binding of factors that block or mask the interaction of translational activators, either by sequestering these translation activation factors or by occupying their interaction sites on the mRNA. These factors could either physically restrict the access of the translational machinery or act by regulating the length of the poly(A)-tail on the transcripts, whose extension is known to precede translational activation ([@b78]).

One of the best-studied mechanisms of translational repression involves the eukaryotic translation initiation factor 4E (eIF4E) pathway ([@b40]). In this repression pathway, mRNAs are prevented from initiating translation that requires the recruitment of the 40S ribosomal subunit through assembly of eIF4F (eIF4G+eIF4E and eIF4A) at the 5′ cap. Translational repressors can bind directly to the mRNA, thus masking the sites for eIF4E binding. For example, the *Drosophila* protein Bruno interacts with Bruno-response elements on mRNA, thus blocking initiation of translation ([@b47]). Alternatively, factors such as the *Drosophila* ovarian protein Cup can bind eIF4E and prevent it from accessing mRNA, thereby inhibiting initiation of translation ([@b19]; [@b65]; [@b72]; [@b104]). Overexpression of eIF4E has been shown to lead to autism-like behavior in mice ([@b80]), and HIV-1 was shown to be able to maintain virus-specific protein synthesis when eIF4E is downregulated ([@b84]). This demonstrates that eIF4E-mediated translational repression is important in a range of cells and circumstances.

A further well-characterised means of controlling the level of proteins synthesis from mRNA is through polyadenylation or deadenylation. In frogs and flies, there are many examples of cytoplasmic polyadenylation elements (CPEs) that reside in the 3′ UTR of mRNA, which are bound by the CPE-binding protein (CPEB) to control translation ([@b17]; [@b20]; [@b33]; [@b76]). Recently, work in the hippocampus of mice has shown that mutants in which the translational repressor of poly(A)-binding protein (PABP) has been knocked out show an increased translation of Ca^2+^/calmodulin-dependent protein kinase II alpha (*Camk2a*) mRNA, a factor involved in many signaling cascades that are regulated by Ca^2+^. Translational activation through the release of PABP-dependent repression has been demonstrated following electrode stimulation and is important for synaptic plasticity and learning ([@b46]).

Mouse models have also highlighted the complexity of translational regulation and revealed new means by which kinase activity regulates mRNA translation. For instance, the mouse protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK, also known as EIF2AK3) has been shown to have a key role in brain function by phosphorylating eIF2α (also known as EIF2A), a key regulator of translational activity ([@b96]). A unique level of intricacy has been shown to be provided by the interaction of fragile X mental retardation 1 (FMRP, also known as FMR1) protein and the human topoisomerase 3-beta-1 (Top3β, also known as TOP3B) ([@b107]), as this complex appears to regulate multiple mRNAs in neurons and -- in Top3β mutants -- there is a reduction in the expression of genes within the neuromuscular junction (NMJ) that are important for neural function. In addition to FMRP, other RNA-binding proteins found in the *Drosophila* nervous system, such as Syncrip (Syp) and Staufen (Stau), have distinct roles in regulation mRNA translation in other stages of development ([@b58]; [@b4]).

Although non-coding RNAs are thought to primarily have a role in mRNA degradation (see following section), an additional role is emerging in translational regulation. In flies, a reversible mechanism for regulating gene expression through the pathway via microRNA (miRNA) and argonaute 2 (AGO2) ([@b63]) involves the phosphorylation of *Drosophila* FMR1 at the synapse. The direct targeting of precursor miRNA -- a long piece of double-stranded RNA (dsRNA) from which mature miRNAs are generated -- to neuronal dendrites has been shown to be mediated by the DEAH-box helicase 36 (DHX36), suggesting that the localisation of precursor miRNA is an important plasticity mechanism ([@b7]). Interestingly, an miRNA-independent mechanism for the recruitment of Argonaute-1 (AGO1) to nanos (*nos*) mRNA in the *Drosophila* early embryo has been described that acts through the smaug protein, suggesting that there are different mechanisms of translational regulation that most likely work in concert ([@b73]).

The recent characterisation of protein components that are involved in translational repression of mRNAs has revealed that the subcellular organisation of protein complexes contributes to efficient translational regulation ([@b3]). Processing bodies (P-bodies) are known locations of mRNA translational control and degradation and have, therefore, been referred to as hubs for RNA metabolism in yeast ([@b1]; reviewed in [@b3]). It has recently been shown that they are also important in regulating developmentally relevant transcripts. We have also shown that it is important where exactly in P-bodies mRNAs localise because the inside of electron-dense P-bodies does not support translation, whereas their localisation at the P-body edge allows translation to occur ([@b102]). Other work from yeast suggests that P-bodies are also the place where mRNAs terminate their journey through the cell ([@b1]; [@b9]).

Degradation {#s1e}
===========

The tight regulation of mRNAs in both space and time ultimately requires mRNA degradation. Although there are several pathways of degradation, the most common is through 5′ to 3′ exonuclease activity, following deadenylation and decapping (reviewed in [@b24]). In yeast, this process is linked with cytoplasmic P-bodies, which are associated with translationally repressed transcripts ([@b93]). These are distinct from stress granules, related cytoplasmic foci that have a similar composition and are likely to share functions. Stress granules assemble under physiological conditions when translation is stalled rather than repressed ([@b10]). Interestingly, recent research indicates that mRNA can be degraded in a 5′ to 3′ fashion as translation is occurring ([@b39]), suggesting that the removal of ribosomes and the activity of exonucleases are not necessarily sequential events.

In *Drosophila*, P-body proteins have been found in neurons and oocytes, and have been suggested to be important for regulating transcripts ([@b4]; [@b102]). In the case of *grk* mRNA, these bodies may be involved in regulating the level of transcripts and act as a dosage and temporal control, although degradation was not explicitly demonstrated in our study ([@b102]). An additional mechanism of mRNA degradation that is relevant for the control of spatially and temporally constrained transcripts is miRNA-mediated degradation. In the case of the maternal to zygotic transition in zebrafish and *Drosophila* embryos, maternal mRNAs are cleared from the embryo by miRNA-mediated deadenylation ([@b12]; [@b30]).

Another mechanism of mRNA regulation is at the level of the DNA sequence, which can affect mRNA levels through the control of decay rates. Recent evidence from yeast shows that DNA promoter elements can affect the decay kinetics of their respective mRNAs after nuclear export ([@b8]).

The specific mechanisms that regulate the degradation of mRNA transcripts after their final localisation have yet to be extensively studied and, thus, the role of P-bodies as sites of degradation remains to be established, mainly owing to the difficulty in characterising these labile bodies and in observing their interactions with mRNA.

Perspectives {#s1f}
============

New imaging technologies, bioinformatics and biochemistry have facilitated major advances in our understanding of the composition, motility and translational regulation of RNP complexes. One successful example of these applications is in the analysis of RNP complex composition of nascent transcripts as they are being processed during splicing in the nucleus and at the NPC.

However, many important questions in the field remain unanswered, such as what is the extent of RNP complex remodeling in the cytoplasm and how is it regulated? How prevalent is the function of small non-coding RNA in the translational regulation of mRNAs? Do the numerous regulatory mechanisms facilitate the localisation of diverse transcripts or are they redundant mechanisms to protect crucial biological processes? The challenge will be to place the biochemical information with regard to the components that are involved in the context of *in vivo* data to fully understand the molecular mechanism of mRNA localisation with respect to cell and tissue function.

###### Box 1. Particle formation

Biochemical and genetic studies have shown how, for localising mRNAs, particular proteins determine each step of their journey (reviewed in [@b45]). Although a diverse array of proteins are involved, these trans-acting factors can be grouped into several classes (see poster).

Understanding the interaction between cis- and trans-acting components, RNP complex composition and remodeling are crucial for understanding the molecular mechanisms underlying mRNA localisation ([@b68]). Assembly of the multiple proteins required for regulating the translational state of the mRNA has been shown to involve numerous sites of weak interaction and involve modification of the mRNA folding ([@b18]; [@b89]). One of the intriguing questions is how the composition of the RNP complexes confers the specific fates of different mRNAs. Although there is evidence that different mRNAs with the same destination are packaged and transported together in the same RNP complex ([@b48]), it was hypothesised that particles with distinct destinations can be distinguished by certain trans-acting factors that are specific for the particular destination ([@b16]). It has been difficult to confirm this hypothesis because many mRNA binding proteins associate with a wide range of different transcripts; for example, the highly conserved double-stranded RNA (dsRNA)-binding protein Staufen (Stau) associates with both *oskar (osk)* and *bicoid (bcd)* mRNA in *Drosophila* oocytes ([@b26]; [@b90]). This notion is further complicated by evidence from biochemical analysis such as the 'atlas' of mammalian mRNA-interacting proteins, which has revealed the enormous diversity of trans-acting factors ([@b14]).

These complex data suggest an alternative view of the specificity of RNP complexes, in that their flexibility in regulating transcripts is based on an unique complement of overlapping cofactors for each mRNA species ([@b14]; [@b15]; [@b45]; [@b58]). A major remaining question is what precise combination of factors is required for the correct localization and translational regulation of each mRNA species, and how this is modified during the life cycle of the transcripts.

###### Box 2. Imaging techniques to study mRNA localisation

Early studies of mRNA localisation were reliant upon *in situ* hybridisation in fixed material, a slow and laborious method. Recent advances in fluorescent *in situ* hybridisation (FISH) now allow the rapid labeling of single mRNA molecules with high sensitivity and selectivity ([@b13]; [@b52]). FISH has also been applied to live cells ([@b79]). However, despite these improvements, *in situ* hybridisation remains limited in its application to certain tissues. An alternative approach to label mRNA in live cells is through injection of *in vitro* synthesized RNA that incorporates fluorescent dyes. By using this technique, it has been possible to rapidly screen a range of mutated RNAs to determine the crucial cis-acting sequences that determine mRNA localisation in *Drosophila* embryos and oocytes ([@b11]; [@b98]).

A breakthrough in live imaging that also emerges as one of the most useful approaches for *in vivo* study of mRNA localisation is the MS2 bacteriophage RNA stem loop bound by MS2 coat protein fusion to a fluorescent protein (MS2-MCP system). It was originally developed in yeast ([@b6]) but has since been extended to several organisms, including *Drosophila* (Forrest et al., 2003), *Mus musculus* ([@b69]), *Xenopus* ([@b28]) and plants ([@b34]). It has also been used to detect nascent mRNA as it is transcribed ([@b36]; [@b109]). Improvements are directed towards maximising the detection of mRNAs, such as by increasing the number and optimisation of MS2 loops ([@b51]). An alternative construct uses the bacteriophage PP7 and also involves the interaction between a stem loop and a viral coat protein ([@b106]). Using the MS2 and PP7 systems in combination might allow the tracking of two different species of mRNAs simultaneously and could provide insights into how transcripts segregate.

However, one limitation of the MS2 and PP7 systems is the potential lack of contrast caused by unbound MCP. This may be overcome by targeting MCP to the nucleus ([@b6]), although this would compromise the ability to follow mRNAs in and around the nucleus. Recently, a combination of MS2 and PP7 has been described that drives a highly specific split-fluorescent protein complementation on the mRNA and allows for high-contrast labeling of individual transcripts ([@b36]).

Furthermore, different tissues present different challenges for imaging approaches, which could be addressed by using advances in imaging techniques. For instance, fast, sensitive widefield microscopy is useful when imaging fast-moving mRNA particles ([@b110]), whereas when imaging within thick samples, such as *Drosophila* embryos, multi-photon microscopy can be useful ([@b86]). Total internal reflection microscopy (TIRF) is ideal for *in vitro* applications because of its high axial resolution ([@b2]), whereas 3D structured illumination microscopy (3D-SIM) gives axial and lateral super-resolution while being flexible enough to be applied when investigating conventionally prepared materials ([@b100]).
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